<html>
<head>PUBMED IDs for CD229</head>
<body bgcolor='#C5F0F2'><h1>CD229</h1><a href='https://pubmed.ncbi.nlm.nih.gov/11477068/'>Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.</a> July 31  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11486275/'>CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells.</a> August 7  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11862385/'>Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.</a> February 28  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12242590/'>Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors.</a> September 21  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15661030/'>Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.</a> January 22  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16720617/'>Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP.</a> May 25  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16720597/'>Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.</a> May 25  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16797413/'>Human Ly9 (CD229) as novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (B-CLL) recognized by autologous CD8+ T cells.</a> June 27  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19824924/'>Co-ordinated regulation of plasmacytoid dendritic cell surface receptors upon stimulation with herpes simplex virus type 1.</a> August 19  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20923684/'>Differential expression of SLAMS and other modulatory molecules by human plasma cells during normal maturation.</a> May 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20933013/'>Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells.</a> May 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20951742/'>Mutual benefits of B-ALL and HLDA/HCDM HLDA 9th Barcelona 2010.</a> May 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21606160/'>Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.</a> February 11  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21670740/'>Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production.</a> March 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21670732/'>Identification of tag haplotypes for 5HTTLPR for different genome-wide SNP platforms.</a> March 6  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23914190/'>Ly9 (CD229) Cell-Surface Receptor is Crucial for the Development of Spontaneous Autoantibody Production to Nuclear Antigens.</a> August 6  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24376606/'>Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.</a> October 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24376606/'>Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.</a> October 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24927415/'>The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection.</a> October 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26130131/'>Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases.</a> November 12  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26303094/'>CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain Significance.</a> January 9  2015<br></body></html>
